Published in J Clin Microbiol on March 01, 1983
Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40
Comparison of rapid identification assays for Staphylococcus aureus. J Clin Microbiol (1984) 2.62
Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis. Microbiol Rev (1985) 2.13
Identification of Staphylococcus species of bovine origin with the API Staph-Ident system. J Clin Microbiol (1983) 1.97
Comparison of the API Staph-Ident and DMS Staph-Trac systems with conventional methods used for the identification of coagulase-negative staphylococci. J Clin Microbiol (1984) 1.63
Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrob Agents Chemother (1990) 1.41
Evaluation of the Staph-Ident and STAPHase systems for identification of staphylococci from bovine intramammary infections. J Clin Microbiol (1984) 1.25
Comparison of modified Minitek system with Staph-Ident system for species identification of coagulase-negative staphylococci. J Clin Microbiol (1987) 1.01
Use of trehalose-mannitol-phosphatase agar to differentiate Staphylococcus epidermidis and Staphylococcus saprophyticus from other coagulase-negative staphylococci. J Clin Microbiol (1984) 0.97
Usefulness of the ID32 staph system and a method based on rRNA gene restriction site polymorphism analysis for species and subspecies identification of staphylococcal clinical isolates. J Clin Microbiol (1992) 0.90
Characterization of Micrococcaceae strains isolated from the human urogenital tract by the conventional scheme and a micromethod. J Clin Microbiol (1985) 0.81
Reproducibility of API Staph-Ident system identifications of coagulase-negative staphylococci isolated from blood. J Clin Microbiol (1990) 0.79
Construction of a database to identify Staphylococcus species. J Clin Pathol (1989) 0.76
Comparison of the API Staph-Ident and DMS Staph Trac micromethods for the identification of coagulase-negative staphylococci. Can J Vet Res (1986) 0.75
Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol (1975) 16.73
Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med (1982) 5.03
Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med (1980) 4.90
Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis (1975) 4.02
Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis (1980) 3.67
Prosthetic valve endocarditis. Analysis of 38 cases. Circulation (1973) 3.29
Septicaemia due to colonization of Spitz-Holter valves by staphylococci. Five cases treated with methicillin. Br Med J (1961) 3.20
Excessive production of mucoid substance in staphylococcus SIIA: a possible factor in colonisation of Holter shunts. Dev Med Child Neurol Suppl (1972) 3.14
Importance of coagulase-negative staphylococci as pathogens in the urinary tract. Lancet (1974) 2.91
Clinical significance of coagulase-negative staphylococci. J Clin Microbiol (1982) 2.77
Staphylococcus saprophyticus: a frequent cause of acute urinary tract infection among female outpatients. J Infect Dis (1978) 2.74
Species identification and susceptibility to 17 antibiotics of coagulase-negative staphylococci isolated from clinical specimens. J Clin Microbiol (1982) 2.58
Significance of coagulase-negative staphylococcal bacteriuria. Lancet (1969) 2.50
Coagulase-negative staphylococci causing endocarditis after cardiac surgery. J Clin Pathol (1973) 2.39
Species of coagulase-negative staphylococci isolated from catheter tips from open-heart surgery patients. Thorax (1980) 2.32
Vascular prosthetic infections: collected experience and results of treatment. Surgery (1977) 2.29
Staphylococcus epidermidis (albus) endophthalmitis. Report of two cases after cataract extraction. Arch Ophthalmol (1973) 2.15
Endocarditis due to Micrococci and Staphylococcus epidermidis. Arch Intern Med (1973) 2.12
The McKee-Farrar total hip replacement. Preliminary results and complications of 368 operations performed in five general hospitals. J Bone Joint Surg Am (1972) 2.08
Total hip replacement with fixation by acrylic cement. A preliminary study of 100 consecutive McKee-Farrar prosthetic replacements. J Bone Joint Surg Am (1972) 2.05
Staphylococcus saprophyticus in the aetiology of nongonococcal urethritis. Br J Vener Dis (1979) 1.97
Subacute bacterial endocarditis due to coagulase-negative Staphylococcus albus. Acta Med Scand (1960) 1.97
Endocarditis caused by coagulase-negative staphylococci. Mayo Clin Proc (1968) 1.84
Nosocomial bacteremia. An epidemiologic overview. Am J Med (1981) 1.84
Significance of coagulase-negative Staphylococcus in urine. J Infect Dis (1973) 1.80
STAPHYLOCOCCUS ALBUS IN WOUND INFECTION AND IN SEPTICEMIA. Can Med Assoc J (1965) 1.69
Urinary tract infections caused by Staphylococcus saprophyticus: recurrences and complications. J Urol (1979) 1.60
The problem of infection in endoprosthetic surgery of the hip joint. Clin Orthop Relat Res (1973) 1.44
Catheter sepsis due to Staphylococcus epidermidis during parenteral nutrition. Surg Gynecol Obstet (1980) 1.34
Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Johns Hopkins Med J (1980) 1.31
Attachment of bacteria to exfoliated cells from the urogenital tract. Invest Urol (1979) 1.21
Outbreak of food-borne gastroenteritis due to a coagulase-negative enterotoxin-producing staphylococcus. N Engl J Med (1971) 1.12
Endemic staphylococcal pseudobacteremia. Infect Control (1981) 1.06
Assessment of the role of Staphylococcus epidermidis as a cause of otitis media. Pediatrics (1973) 0.97
Toxins and enzymes of coagulase negative staphylococci isolated from human infections. J Hyg Epidemiol Microbiol Immunol (1974) 0.95
Coagulase-negative staphylococci. Infect Control (1982) 0.86
Epidemic conjunctivitis in the newborn associated with coagulase negative staphylococci. J Obstet Gynaecol Br Commonw (1966) 0.84
The "five minute" consultation: effect of time constraint on clinical content and patient satisfaction. Br Med J (Clin Res Ed) (1986) 15.01
Comparison of micro-ID, API 20E, and conventional media systems in identification of Enterobacteriaceae. J Clin Microbiol (1978) 7.65
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83
The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther (1973) 4.56
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88
Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) (1985) 2.67
Comparison of rapid identification assays for Staphylococcus aureus. J Clin Microbiol (1984) 2.62
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62
Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol (1983) 2.11
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med (1978) 2.04
The involvement of the frontal lobes in cognitive estimation. Cortex (1978) 2.02
Preparation of Scarlet Fever Toxin. Am J Public Health Nations Health (1939) 2.02
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Antimicrob Agents Chemother (1985) 2.02
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98
The fate of ( 14 C)disodium cromoglycate in man. J Pharm Pharmacol (1972) 1.97
Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92
The metabolism of salbutamol in man. Xenobiotica (1973) 1.88
Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis (1989) 1.80
Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone. Clin Infect Dis (1998) 1.80
Patterns of antibiotic-resistant Streptococcus pneumoniae in children in a day-care setting. J Fam Pract (1998) 1.80
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74
Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63
Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother (1990) 1.59
Increasing hospital employee participation in an influenza vaccine program. Am J Infect Control (1998) 1.52
Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria. Biochem J (1970) 1.51
The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients. Am Rev Respir Dis (1973) 1.51
Multicenter in vitro evaluation of SM-7338, a new carbapenem. Antimicrob Agents Chemother (1989) 1.50
Correlation studies of entero-set 20, API 20E and conventional media systems for Enterobacteriaceae identification. J Clin Microbiol (1981) 1.48
Pharmacokinetics of inhaled salbutamol in asthmatic patients. Br J Pharmacol (1971) 1.47
An evaluation of statewide strategies to reduce antibiotic overuse. Fam Med (2000) 1.43
Potential interaction between isoniazid and selective serotonin-reuptake inhibitors. Am J Health Syst Pharm (1995) 1.43
Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother (1984) 1.40
Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. J Clin Microbiol (1985) 1.40
The expanding horizons of infection control. Infect Control Hosp Epidemiol (1995) 1.39
Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J Med Microbiol (1983) 1.29
Mycoplasma-dependent activation of normal lymphocytes: mitogenic potential of mycoplasmas for mouse lymphocytes. Infect Immun (1977) 1.24
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob Agents Chemother (1987) 1.23
Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis (1996) 1.22
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis (1991) 1.21
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.19
The fate of (3H)salbutamol in man. Biochem J (1971) 1.13
Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med (1987) 1.10
Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1992) 1.09
Mycoplasma-dependent activation of normal lymphocytes: induction of a lymphocyte-mediated cytotoxicity for allogeneic and syngeneic mouse target cells. Infect Immun (1977) 1.09
Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury. Gut (2005) 1.09
Candidal suppurative peripheral thrombophlebitis. Ann Intern Med (1982) 1.08
Sensitivity, specificity, and predictive value of body surface cultures in a neonatal intensive care unit. JAMA (1988) 1.08
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing. Diagn Microbiol Infect Dis (1988) 1.07
Endemic staphylococcal pseudobacteremia. Infect Control (1981) 1.06
Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae. Clin Infect Dis (1995) 1.06
Levofloxacin failure in a patient with pneumococcal pneumonia. Ann Pharmacother (2001) 1.04
Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1985) 1.03
Growth and cytopathology of Mycoplasma synoviae in chicken embryo cell cultures. Infect Immun (1975) 1.02
Tularemia and rhabdomyolysis. JAMA (1985) 1.02
Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J Infect Dis (1989) 1.00
In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels. Diagn Microbiol Infect Dis (1995) 1.00
Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media. J Clin Microbiol (1995) 1.00
Tuberculoid tenosynovitis and carpal tunnel syndrome caused by Mycobacterium szulgai. Am J Med (1978) 0.99
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. J Antimicrob Chemother (1986) 0.98
Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain. N Engl J Med (1975) 0.98
Short-course parenteral antibiotic therapy for pyelonephritis in pregnancy. South Med J (1984) 0.97
Epidemiological spectrum and current treatment of listeriosis. Rev Infect Dis (1992) 0.97
Mycoplasma-dependent activation of normal mouse lymphocytes: requirement for functional T lymphocytes in the cytotoxicity reaction mediated by Mycoplasma arthritidis. Infect Immun (1980) 0.96
Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrob Agents Chemother (1995) 0.95
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years. Diagn Microbiol Infect Dis (1995) 0.95
Molecular epidemiology of multiply antibiotic-resistant Shigella flexneri in Fortaleza, Brazil. J Clin Microbiol (1997) 0.94
Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother (1986) 0.93
Controlled evaluation of modified radiometric blood culture medium supplemented with gelatin for detection of bacteremia and fungemia. J Clin Microbiol (1987) 0.93
Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria. Rev Infect Dis (1990) 0.93
The fate of salbutamol administered by intermittent positive pressure breathing. Br J Pharmacol (1972) 0.92
Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol (1998) 0.92
Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group. J Clin Microbiol (1987) 0.92
Francisella tularensis. Infect Control (1985) 0.91
Rapid diagnosis of Candida sepsis in surgical patients. Am Surg (1987) 0.91
Hemophilus influenzae pneumonia in adults: report of five cases caused by ampicillin-resistant strains. Am Rev Respir Dis (1980) 0.90
Immunofluorescence and electron microscopy of the attachment of Mycoplasma synoviae to chicken embryo fibroblasts. Infect Immun (1978) 0.90
Absorption of drugs by the lung. Br J Clin Pharmacol (1976) 0.90
Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin. J Antimicrob Chemother (1983) 0.89
Comparison of the effect of refrigerated versus room temperature media on the isolation of Neisseria gonorrhoeae from genital specimens. J Clin Microbiol (1985) 0.89
Synergistic resistance mechanisms in Pseudomonas aeruginosa. J Antimicrob Chemother (1987) 0.89
In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides. Diagn Microbiol Infect Dis (1984) 0.89
Selection of fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus with ciprofloxacin and trovafloxacin. Antimicrob Agents Chemother (1998) 0.88
Rubella immunization of hospital personnel: a debate. Infect Control (1982) 0.88
The effect of R antigen on the attachment of Bdellovibrio bacteriovorus to Salmonella typhimurium. Acta Microbiol Pol A (1974) 0.87
Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria. Infect Immun (1993) 0.87
Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori. Antimicrob Agents Chemother (1995) 0.87
Mycoplasma-dependent activation of normal lymphocytes: role of arginine and nonviable mycoplasma antigen in the induction of lymphocyte-mediated cytotoxicity for syngeneic mouse target cells. Infect Immun (1977) 0.87